Patrick Mayeux

Pure Red-Cell Aplasia and Antierythropoietin Antibodies in Patients Treated with Recombinant Erythropoietin

Nicole Casadevall, J Nataf, B Viron et al. · New England Journal of Medicine · 2002 · 1.2K citations

Medicine, Hematology, Immunology +11

Targeting glutaminolysis has antileukemic activity in acute myeloid leukemia and synergizes with BCL-2 inhibition

Nathalie Jacque, Anne Marie Ronchetti, Clément Larrue et al. · Blood · 2015 · 384 citations · Full text

Medicine, Oncology, Pharmacology +16

Role of the phosphatidylinositol 3-kinase/Akt and mTOR/P70S6-kinase pathways in the proliferation and apoptosis in multiple myeloma

Frédéric Pène, Yann-Érick Claessens, O. Müller et al. · Oncogene · 2002 · 298 citations

Life Sciences, Cell Biology, Oncology +13

Inhibiting glutamine uptake represents an attractive new strategy for treating acute myeloid leukemia

Lise Willems, Nathalie Jacque, Arnaud Jacquel et al. · Blood · 2013 · 286 citations

Medicine, Oncology, Pharmacology +8

Mammalian target of rapamycin (mTOR) inhibition activates phosphatidylinositol 3-kinase/Akt by up-regulating insulin-like growth factor-1 receptor signaling in acute myeloid leukemia: rationale for therapeutic inhibition of both pathways

Jérôme Tamburini, Nicolas Chapuis, Valérie Bardet et al. · Blood · 2007 · 252 citations

Medicine, Oncology, Pharmacology +16